Related Party Transactions (Details Narrative) - USD ($) $ in Thousands |
1 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|
Jan. 31, 2020 |
Jan. 22, 2020 |
Dec. 31, 2018 |
Dec. 31, 2019 |
May 15, 2017 |
|
Percentage of holder of common stock | 50.00% | ||||
Subsequent Event [Member] | |||||
License agreement, description | The Company entered into a license agreement (the "Shared Space Agreement") with Orchestra BioMed, Inc., a greater than 5% holder of our common stock and in which David Hochman, the Chairman of our board of directors, served as the Chairman of the board of directors, and Darren Sherman, a member of our board of directors, served as a director and chief operating officer, to grant the use of 35% of the Fort Lauderdale premises and shall expand to approximately 60% to 70% of the premises during the term. | ||||
Shared Space Agreement [Memeber] | |||||
Percentage of holder of common stock | 5.00% | ||||
Shared Space Agreement [Memeber] | Subsequent Event [Member] | |||||
Shared space agreement, description | The Company a one-time fee of $28.5, upon entering into the Shared Space agreement, of which $10.5 was payment for occupancy of the office space in January 2020 prior to the effective date of the Shared Space, Agreement, and $18 was payment of the receivable for 2019 usage of the office space. Orchestra BioMed, Inc. will continue to pay a monthly license fee to the Company until the expiration of the Shared Space Agreement in September 2024. Aggregate license fees will generally range from approximately $162 to approximately $198 in any given calendar year during the term of the Shared Space Agreement. | ||||
Sales & Marketing Services Arrangement [Member] | FreeHold Surgical, Inc. [Member] | |||||
Accounts payable | $ 8 | $ 8 | |||
General and administrative expense | 192 | ||||
Other current assets | $ 18 | ||||
Shareholder Loan [Member] | |||||
Principal balance | $ 122 | ||||
Loan interest rate | 3.40% | ||||
Finance income | $ 4 |
X | ||||||||||
- Definition Description of license agreement. No definition available.
|
X | ||||||||||
- Definition Amount for accounts payable to related parties. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of current assets classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party. No definition available.
|
X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|